Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication October 30, 2023
- Revision received March 25, 2024
- Published online May 6, 2024.
Copyright & Usage
© 2024 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Weidong Yang*,1,
- Fei Kang*,1,
- Yue Chen2,
- Zhaohui Zhu3,
- Feng Wang4,
- Chunxia Qin5,
- Jin Du6,
- Xiaoli Lan5 and
- Jing Wang1
- 1Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi’an, China;
- 2Department of Nuclear Medicine, Affiliated Hospital of Southwest Medical University, Luzhou, China;
- 3Department of Nuclear Medicine, Peking Union Medical College Hospital, Beijing, China;
- 4Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China;
- 5Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; and
- 6China Isotope and Radiation Corporation, Beijing, China
- For correspondence or reprints, contact Xiaoli Lan (hzslxl{at}163.com) or Jing Wang (13909245902{at}163.com).
↵* Contributed equally to this work.
Statistics from Altmetric.com
Cited By...
Article usage
In this issue
Jump to section
- Article
- Visual Abstract
- Abstract
- MILESTONES OF NUCLEAR MEDICINE IN CHINA
- STATUS OF CURRENT NUCLEAR MEDICINE
- PRODUCTION OF MEDICAL RADIOISOTOPES
- COMMERCIAL RADIOPHARMACEUTICALS
- DOMESTIC ADVANCED EQUIPMENT
- RESEARCH AND FUNDING OF NUCLEAR MEDICINE
- POTENTIAL OF NUCLEAR MEDICINE IN CHINA
- PROGRESS IN THERANOSTICS IN CHINA
- 68GA/177LU THERANOSTICS FOR NEUROENDOCRINE TUMOR
- 68GA/177LU THERANOSTICS FOR PROSTATE CANCER
- 68GA/177LU THERANOSTICS BY TARGETING FAP
- THERANOSTICS FOR BONE METASTASIS
- OTHERS
- PROCEDURES AND CHALLENGES OF THERANOSTICS
- THE FUTURE
- DISCLOSURE
- ACKNOWLEDGMENTS
- REFERENCES
- Figures & Data
- Info & Metrics